T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection
Abstract
Long-lived clonal T cells deficient in CD28 expression are commonly found in patients with inflammatory syndromes and persistent infections. Considering that CD28 loss is the most consistent immunological marker of aging, we propose that, in pathological states, CD28(null) T cells represent prematurely senescent cells resulting from persistent immune activation. These unusual lymphocytes have aberrant functions that contribute to disease-related immune abnormalities, and the degree of accumulation of CD28(null) T cells predicts the severity of clinical manifestations. We suggest that understanding of the biological properties of T cells that have reached replicative senescence will influence the future management of certain diseases. Indeed, studies on the molecular basis for the loss of CD28 are already providing information on methods to functionally rescue senescent T cells.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Cells in younger patients may become senescent, and chronic activation and proliferation may cause T cell senescence.
“This suggests that cells in younger patients may become senescent, and chronic activation and proliferation may still cause T cell senescence [55].”
From T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment (2013) · cites this paper as [55]
The citation lists haven’t been fetched yet
References 76 · Cited by 223
- Authors
- Vallejo, A. N., Weyand, C. M., & Goronzy, J. J.
- Affiliations
- Mayo Clinic (US)
- Emory University (US)
- Corresponding author
- Vallejo, Abbe N.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 10
- Issue
- 3
- Pages
- 119-124
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W1993094191
- Cited by
- 223
- References
- 76
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 3 · 2023: 4 · 2022: 8 · 2021: 10 · 2020: 12 · 2019: 10 · 2018: 11 · 2017: 17 · 2016: 8 · 2015: 12 · 2014: 10 · 2013: 14 · 2012: 12
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (R01-AG15043, R01-AG22379, R01-AI44142, R01-AR41974, R01-AR42527)
- Emory University
- Mayo Foundation for Medical Education and Research
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- T cell senescence, replicative senescence, chronic inflammation, persistent infection, immunosenescence, immune activation, disease severity
- MeSH terms
- Chronic Disease, Humans, Infections, Inflammation, Syndrome, T-Lymphocytes, Cellular Senescence, CD28 Antigens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review